- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03228888
Effects of Ecological Rythmic-acoustic Stimulation (E-RAS) on Motor Skills in Individuals With Parkinson's Disease
Effects of Ecological Rythmic-acoustic Stimulation (E-RAS) on Motor Skills in Individuals
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cagliari, Italy, 09100
- General Hospital "G. Brotzu"
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis of PD according to the UK Brain Bank criteria;
- ability to walk independently;
- absence of relevant hearing impairments which could prevent the correct perception of the auditory cues;
- absence of significant cognitive impairment (i.e., Mini-Mental Status Examination (MMSE) > 24; Frontal Assessment Battery (FAB) > 13);
- absence of psychiatric or severe systemic illnesses;
- mild-to-moderate disability assessed by means of the modified Hoehn and Yahr (H&Y) staging scale (1,5 ≤ H&Y ≤ 3);
- no engagement in any rehabilitative program in the 3 months before the beginning of the study
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Artificial Sounds
Participants were provided headphones and a portable MP3 device which played a metronome tick at specified rhythm calculated as follows: a) if a patient's cadence was below the normality, the BPM of the stimulus was set at a value of 10% higher than one's own cadence; b) if a patient's cadence was below, but close to normality (less than 10% difference), the BPM of the stimulus was set at normality values; c) if a patient's cadence was above the normality, the BPM of the stimulus was set at a value equal to one's own cadence. Participants performed daily 30 minutes of walking assisted by the rhythmic acoustic stimuli. |
The intervention consist in 5 weeks, 20 min/day gait training assisted by rhythmic acoustic stimuli administered using a portable MP3 player
|
|
EXPERIMENTAL: Ecological Sounds
Participants were provided headphones and a portable MP3 device which played an ecological rhythmic sound obtained by actual footsteps of human at specified rhythm calculated as follows: a) if a patient's cadence was below the normality, the BPM of the stimulus was set at a value of 10% higher than one's own cadence; b) if a patient's cadence was below, but close to normality (less than 10% difference), the BPM of the stimulus was set at normality values; c) if a patient's cadence was above the normality, the BPM of the stimulus was set at a value equal to one's own cadence. Participants performed daily 30 minutes of walking assisted by the rhythmic acoustic stimuli. |
The intervention consist in 5 weeks, 20 min/day gait training assisted by rhythmic acoustic stimuli administered using a portable MP3 player
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Walking speed
Time Frame: 5 weeks
|
Walking speed calculated on a 10 m path using motion-capture system
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hip Flexion-extension
Time Frame: 5 weeks
|
Angle of flexion-extension of hip joint during a gait cycle
|
5 weeks
|
|
Knee Flexion-extension
Time Frame: 5 weeks
|
Angle of flexion-extension of knee joint during a gait cycle
|
5 weeks
|
|
Ankle Dorsi- Plantar-flexion
Time Frame: 5 weeks
|
Angle of dorsi- plantar-flexion of ankle joint during a gait cycle
|
5 weeks
|
|
GPS
Time Frame: 5 weeks
|
Gait Profile Score (synthetic index of deviation from a physiologic gait pattern)
|
5 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PG/2014/17870
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
Bezmialem Vakif UniversityIstanbul University - CerrahpasaNot yet recruitingParkinson Disease | PARKINSON DISEASE (Disorder) | Parkinson Disease (PD), Postural Balance
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
Clinical Trials on Administration of rhytmic acoustic stimuli for gait training
-
Spaulding Rehabilitation HospitalGoldenGait LTDActive, not recruitingStroke | Hemiplegia | Gait, HemiplegicUnited States
-
Diana KamalEnrolling by invitationKnee Osteoarthritis | Ultrasound | Quality of Life (QOL) | Physical Performance ParametersRomania
-
Hvidovre University HospitalRecruitingDeep Vein Thrombosis (DVT)Denmark
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Head and Neck NeoplasmUnited States
-
Jiangsu Famous Medical Technology Co., Ltd.Ruijin HospitalCompletedNovel Coronavirus PneumoniaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Blasts More Than 10 Percent of Bone Marrow Nucleated CellsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingPancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Advanced Pancreatic AdenocarcinomaUnited States
-
Washington University School of MedicineNational Institute of Mental Health (NIMH); University of California, San FranciscoActive, not recruiting
-
Fred Hutchinson Cancer CenterMerck Sharp & Dohme LLCNot yet recruitingHuman Papillomavirus-Related CarcinomaUnited States
-
UMC UtrechtNational University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaboratorsRecruitingCommunity-acquired Pneumonia, Influenza, COVID-19United Kingdom, United States, Canada, Australia, Netherlands, Spain, Croatia, Belgium, New Zealand, Ireland, France, Italy, Japan, Slovenia, Colombia, India, Nepal, Pakistan, Portugal, Saudi Arabia, Germany, Israel, Czechia, Estonia, F... and more